Add BrightSurf on Google Email

Study finds significantly worse outcomes in cancer patients with cognitive impairment

A new study found that cancer patients with dementia have a lower survival rate than those without dementia, even after controlling for age, tumor type, and stage. Patients with mild cognitive impairment can still live independently for nearly four and a half years, while those with moderate to severe dementia have an average survival ...

SourceUniversity of Georgia·JournalCritical Reviews in Oncology/Hematology·DateDec 14, 2009

Dementia, not blindness, is overwhelmingly the most important contributor to disability in elderly people in low- and middle-income countries

A study of 15,000 elderly individuals in 11 low- and middle-income countries found dementia to be the largest contributor to disability, followed by stroke, limb impairment, and depression. Chronic diseases, including those of the brain and mind, pose significant challenges for carers and society.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 26, 2009

Unravelling the pathology of dementia

A study published in PLOS Medicine found that dementia is often associated with mixed pathological changes, including Alzheimer's and vascular dementia. The researchers estimated that drugs targeting specific pathologies may have limited impact on the overall burden of dementia.

SourcePLOS·JournalPLOS Medicine·DateNov 9, 2009

Older patients with dementia at increased risk for flu mortality

A study published in Journal of the American Geriatrics Society found that older patients with dementia are diagnosed with flu less frequently, have shorter hospital stays, but a higher rate of death. The study highlights the need for refined guidelines on flu immunization and treatment in this vulnerable population.

SourceTufts University, Health Sciences Campus·JournalJournal of the American Geriatrics Society·DateOct 27, 2009

Dying from dementia

Palliative care is crucial for dementia patients as they often suffer from untreated pain and symptoms due to their inability to report their condition. The need for improved symptom management, emotional support, and family support has been emphasized by experts.

SourceIndiana University School of Medicine·JournalNew England Journal of Medicine·DateOct 14, 2009

Institute for Aging Research study says dementia is a terminal illness

A study published in the New England Journal of Medicine found that dementia is a terminal illness characterized by uncomfortable symptoms and high mortality rates. The research highlights the need for improved palliative care in nursing homes to reduce physical suffering and enhance communication with family members.

Multiple strokes rather than underlying vascular risk factors increase risk of post-stroke dementia

A systematic review found that post-stroke dementia rates varied greatly, but were closely related to stroke characteristics and complications. The authors suggest that optimum acute stroke care and secondary prevention measures could reduce the burden of dementia. Further studies are needed to identify independent predictive factors.

SourceThe Lancet_DELETED·JournalThe Lancet Neurology·DateSep 23, 2009

Groups are key to good health

Research by the Universities of Exeter and Queensland shows that membership of social groups has a positive impact on health and well-being. Studies have found that people who maintain valued group memberships recover more positively after a stroke, are happier in care homes, and experience improved mental health.

HIV subtype linked to increased likelihood for dementia

A new study by Johns Hopkins researchers reveals that HIV subtype D is associated with a significantly higher likelihood of developing dementia. The study found that nearly all (89%) patients infected with subtype D developed dementia, whereas only about 24% of those infected with subtype A showed signs of the condition.

SourceJohns Hopkins Medicine·JournalClinical Infectious Diseases·DateAug 28, 2009

Off-label use: Oft not evidence based

A recent national survey found that physicians inaccurately believed in the FDA approval status of 22 drug-indication pairs, including lorazepam for chronic anxiety and quetiapine for dementia with agitation. The study highlights the need for better methods to inform physicians about the level of evidence supporting off-label drug use.

SourceUniversity of Chicago Medical Center·JournalPharmacoepidemiology and Drug Safety·DateAug 21, 2009

Neural networks mapped in dementia patients

A study mapping brain activity networks in Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) patients reveals distinct changes in communication between brain areas. AD patients show more random network organization, while FTLD patients display a more ordered structure, challenging the understanding of these diseases.

SourceBMC (BioMed Central)·JournalBMC Neuroscience·DateAug 20, 2009

Breakthrough in Alzheimer's research

A large multicentre study has confirmed that a combination of proteins in the cerebrospinal fluid can reliably identify patients with early symptoms of dementia who will later develop full-blown Alzheimer's disease. The findings may lead to new medicines and point-of-care diagnostics.

SourceUniversity of Gothenburg·JournalJAMA·DateAug 12, 2009

Large epidemiologic study supports brain power of fish in older people

A recent study published in the American Journal of Clinical Nutrition found an inverse association between fish consumption and dementia prevalence in older adults across 7 middle- to low-income countries. Higher fish consumption was linked to a lower risk of dementia, contradicting previous findings from industrialized countries.

SourceAmerican Society for Nutrition - 2017·JournalAmerican Journal of Clinical Nutrition·DateJul 17, 2009

Caregivers may benefit from adult day care

Adult day care can help alleviate caregiver stress by lifting responsibility for a few hours, promoting sleep and well-being in those cared for. The study will assess the impact of day care on caregivers' health and stress levels over three years with 180 participants.

Mount Sinai researchers discover novel mechanisms that might causally link type 2 diabetes to Alzheimer's disease

A recent study by Mount Sinai faculty suggests that a gene associated with type-2 diabetes decreases in Alzheimer's disease dementia cases. The research found that promoting PGC-1 content in brain cells attenuates hyperglycemic-mediated β-amyloid production, linking type-2 diabetic metabolic defects to increasing dementia.